Detalles de la búsqueda
1.
Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer.
Cancer Immunol Immunother
; 73(7): 119, 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38713205
2.
Phase I study of the Syk inhibitor sovleplenib in relapsed or refractory mature B-cell tumors.
Haematologica
; 2024 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38235512
3.
Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib.
Chin J Cancer Res
; 35(5): 526-535, 2023 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37969958
4.
Platelet Distribution Width: A Significant Predictor of Poor Outcome After Mechanical Thrombectomy.
J Stroke Cerebrovasc Dis
; 31(3): 106273, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34974240
5.
Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib in the FRESCO trial.
Future Oncol
; 17(15): 1923-1931, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33563040
6.
Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study.
Lancet Oncol
; 21(11): 1500-1512, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32966811
7.
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer: The FRESCO Randomized Clinical Trial.
JAMA
; 319(24): 2486-2496, 2018 06 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29946728
8.
Gender differences in psychological morbidity, burnout, job stress and job satisfaction among Chinese neurologists: a national cross-sectional study.
Psychol Health Med
; 22(6): 680-692, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27436373
9.
Quantitative Proteomic Analysis Reveals Molecular Adaptations in the Hippocampal Synaptic Active Zone of Chronic Mild Stress-Unsusceptible Rats.
Int J Neuropsychopharmacol
; 19(1)2015 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26364272
10.
Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trial.
Eur J Cancer
; 199: 113539, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38237373
11.
Acute tryptophan depletion reduces nitric oxide synthase in the rat hippocampus.
Neurochem Res
; 38(12): 2595-603, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24170240
12.
Phase 1b/2 trial of fruquintinib plus sintilimab in treating advanced solid tumours: The dose-escalation and metastatic colorectal cancer cohort in the dose-expansion phases.
Eur J Cancer
; 181: 26-37, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36628898
13.
Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 study.
Lancet Haematol
; 10(6): e406-e418, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37028433
14.
PPM1K mediates metabolic disorder of branched-chain amino acid and regulates cerebral ischemia-reperfusion injury by activating ferroptosis in neurons.
Cell Death Dis
; 14(9): 634, 2023 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37752100
15.
Health-related quality of life in patients with advanced well-differentiated pancreatic and extrapancreatic neuroendocrine tumors treated with surufatinib versus placebo: Results from two randomized, double-blind, phase III trials (SANET-p and SANET-ep).
Eur J Cancer
; 169: 1-9, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35489301
16.
Long-Term Efficacy, Safety, and Subgroup Analysis of Savolitinib in Chinese Patients With NSCLCs Harboring MET Exon 14 Skipping Alterations.
JTO Clin Res Rep
; 3(10): 100407, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36217329
17.
Absorption, Metabolism and Excretion of Surufatinib in Rats and Humans.
Curr Drug Metab
; 21(5): 357-367, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32407271
18.
Surufatinib in Chinese Patients with Locally Advanced or Metastatic Differentiated Thyroid Cancer and Medullary Thyroid Cancer: A Multicenter, Open-Label, Phase II Trial.
Thyroid
; 30(9): 1245-1253, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32075524
19.
Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of the Phase 3 FRESCO Trial.
Adv Ther
; 37(11): 4585-4598, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32901330
20.
Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics.
Neuropsychiatr Dis Treat
; 15: 867-881, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31118636